Electronic monitors reveal HIV medication habits in pregnancy and beyond

NCT ID NCT01621347

Completed Knowledge-focused Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study examines how consistently pregnant women with HIV take their antiretroviral medication during pregnancy and after childbirth. Using electronic monitoring devices, pill counts, and interviews, researchers track changes in adherence and record the barriers and facilitators women face. The goal is to understand when and why adherence may change, helping improve support for mothers living with HIV.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: antiretroviral therapy
What this could lead to: If successful, this study could help identify when and why adherence drops, leading to better support for pregnant women with HIV.
What could go wrong: This is a small, retrospective study that only observes past behavior, so it cannot prove what causes changes in adherence or apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV INFECTION PREGNANCY

Contacts and locations

Show contact details

Locations

Policlinique Médicale Universitaire

Lausanne, Canton of Vaud, 1011, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.